Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 5/20 | 0.32 |
| ▸ | FABP5 | Q01469 | 4/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene Glycol SCHEMBL2166957 | 0.95 | FABP4 (0.33) | FABP4FABP5HSD17B10ACLYKDM4E | |
| 1,4-Butanediol SCHEMBL2166784 | 0.90 | FABP4 (0.36) | FABP4FABP5HSD17B10ACLYKDM4E | |
| SCHEMBL2168120 | 0.89 | FABP4 (0.34) | FABP4FABP5HSD17B10ACLYMEN1 | |
| 1,4-Butanediol SCHEMBL2831393 | 0.88 | HSD17B10 (0.38) | HSD17B10KDM4EFFAR1FFAR4MEN1 | |
| SCHEMBL2168217 | 0.86 | KMT2A (0.36) | ALDH1A1MEN1KMT2AMAPK1 | |
| 1,3-Propanediol SCHEMBL2834709 | 0.86 | HSD17B10 (0.38) | HSD17B10CYP2C9FFAR1FFAR4MEN1 | |
| Ethylene Glycol SCHEMBL2166684 | 0.84 | FABP4 (0.38) | FABP4FABP5HSD17B10ACLYKDM4E | |
| Ethylene Glycol SCHEMBL2829965 | 0.83 | HSD17B10 (0.40) | HSD17B10CYP2C9MEN1KMT2AMAPK1 | |
| SCHEMBL2166953 | 0.82 | KMT2A (0.33) | HSD17B10KDM4EALDH1A1HPGDMEN1 | |
| SCHEMBL607945 | 0.80 | HSD17B10 (0.44) | HSD17B10KDM4EALDH1A1CYP2C9HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383274-B2 | Nonaqueous electrolyte solution for lithium battery, lithium battery using same, and formyloxy group-containing compound used therein | UBE INDUSTRIES, LTD. (JP) | 2013-02-26 | — | — | US | disclosed |
| US-20110183199-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM BATTERY, LITHIUM BATTERY USING SAME, AND FORMYLOXY GROUP-CONTAINING COMPOUND USED THEREIN | UBE INDUSTRIES, LTD. (JP) | 2011-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110183199-A1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR LITHIUM BATTERY, LITHIUM BATTERY USING SAME, AND FORMYLOXY GROUP-CONTAINING COMPOUND USED THEREIN | HCN2, KCNN2, KCNB1 | FABP4 3859/4885FABP5 2585/4885HSD17B10 209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.